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Abstract
Phospholipids are essential components of all biological membranes. Phosphatidylcholine (PC) and
Phosphatidylserine (PS) are Phosphatidyl-phospholipids that are required for normal cellular
structure and function. The participation in physical activity often challenges a variety of
physiological systems; consequently, the ability to maintain normal cellular function during activity
can determine sporting performance. The participation in prolonged intense exercise has been
shown to reduce circulatory choline concentrations in some individuals. As choline is a pre-cursor
to the neurotransmitter Acetylcholine, this finding has encouraged researchers to investigate the
hypothesis that supplementation with PC (or choline salts) could enhance sporting performance.
Although the available data that evaluates the effects of PC supplementation on performance are
equivocal, acute oral supplementation with PC (~0.2 g PC per kg body mass) has been
demonstrated to improve performance in a variety of sporting activities where exercise has
depleted circulatory choline concentrations. Short term oral supplementation with soy-derived PS
(S-PS) has been reported to attenuate circulating cortisol concentrations, improve perceived well-
being, and reduce perceived muscle soreness after exercise. More recently, short term oral
supplementation (750 mg per day of S-PS for 10 days) has been demonstrated to improve exercise
capacity during high intensity cycling and tended to increase performance during intermittent
running. Although more research is warranted to determine minimum dietary Phospholipid
requirements for optimal sporting performance, these findings suggest that some participants might
benefit from dietary interventions that increase the intakes of PC and PS.
Background
The functional ingredients of Lecithin are Phosphorus
containing lipids called Phospholipids (PL). Hundreds of
different PL molecules have been described, but the major
types are the phosphatidyl-phospholipids. They consist of
two fatty acids groups that are connected through a glyc-
erol backbone to a Phosphate ester group. Phospholipids
are essential building blocks of all biological membrane
systems and act not only as structural molecules but also
as dynamic, functionally important components of cells
[1].
Phosphatidylcholine (PC) is a major constituent of all cel-
lular membranes and its presence is necessary for normal
function. Phosphatidylcholine builds a continuous mem-
brane matrix, providing precise fluidity, charge distribu-
tion and electronic character that enzymes and other
membrane molecules need to carry out their functions.
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Supplies of PC are needed to support membrane expan-
sion as the cells grow, for membrane renewal, and for the
regeneration of the cells' membrane system following
damage. Phosphatidylcholine also operates in the liver,
lungs, gastro intestinal tract and kidneys as a surface-
active wetting-agent to coat cell linings. Phosphatidylcho-
line supplementation have been found to support healthy
cholesterol levels [2], liver [3] and brain functions [4] and
due to the essential nutrient choline, which comprises
about 15% of the PC molecule, PC supplementation
might be beneficial for endurance athletes [5].
Phosphatidylserine (PS) [6] is present in all biological
membranes of animals, higher plants and micro organ-
isms. In humans, PS is most concentrated in the brain
where it comprises 15% of the total phospholipid pool. In
other human tissue the ratio of PS in the Phospholipid
pool varies: lungs (7.4%), testes (6.4%), kidneys (5.7%),
liver (3.8%), skeletal muscle (3.3%), heart (3.2%) and
blood plasma (0.2%). The total body PS pool is estimated
to be approximately 60 grams, with 30 grams in the brain
and 30 grams in the rest of the body. The average daily PS
intake from the diet in western countries is estimated to be
130 mg [7]. Phosphatidylserine is located mainly in the
internal layer of the cell membrane and has a variety of
unique structural and regulatory functions. Phosphatidyl-
serine is involved in governing membrane fluidity and
therefore in the regulation of biological cell activities. As
PS exhibits direct and indirect interactions with integral
and membrane-associated proteins, it modulates the
activity of receptors, enzymes, ion channels and signalling
molecules. Phosphatidylserine supplementation
improves brain functions that tend to decline with age [8].
Recent studies indicate that PS supplementation might be
beneficial for children with attention deficit hyperactivity
disorder [9] and young people suffering from mental [10]
and/or physical stress [11].
Phosphatidylcholine
Intense exercise lowers choline levels
Muscle contractions are induced by signals carried along
cholinergic nerves to the muscle fiber. Acetylcholine, the
signaling molecule or neurotransmitter, is synthesized
from choline. The concentration of free choline can influ-
ence the rates in which acetylcholine is synthesized and
released [12-15]. Consequently, a reduction in free
choline during intense physical activity might reduce ace-
tylcholine release and thereby affect endurance and per-
formance.
Intense exercise of long duration relies extensively on the
muscle contraction signaling pathway. Strenuous exercise
has been reported to result in decreased choline concen-
trations within the blood. For example, runners of the
1985 and 1986 Boston Marathon showed a 40% drop in
plasma choline levels [16,17] (see figure 1); reductions in
circulatory choline have also been reported in cyclists
[5,18], and runners [18-20].
Phosphatidylcholine Supplementation Increases Choline 
Levels
Several studies have shown that choline supplementation
is able to significantly increase plasma choline levels
[21,22]. Phosphatidylcholine is 12 times more effective
than inorganic choline salts at raising human blood
choline levels after 24 hours [21,22]. Following the inges-
tion of choline chloride, serum levels reach their peak
(86% above normal levels) after approximately 30 min-
utes and return to normal values within 4 hours 21. Ingest-
ing PC resulted in higher peak serum choline
concentrations (265% above normal levels) and these lev-
els remained elevated for 12 hours [21] (see figure 2).
The oral ingestion of inorganic choline salts (e.g. choline
chloride, choline citrate, choline bitartrate) leads to losses
of approximately 60% of the available choline, through
conversion to trimethylamine by intestinal bacteria [23].
The same amount of choline ingested in the form of PC
produces only one third of the trimethylamine [24]. High
amounts of trimethylamine in the gastrointestinal tract
can produce an offensive, fishy body odor.
Runners in the Boston marathon showed a decrease in  plasma choline levels of about 40% [16,17] Figure 1
Runners in the Boston marathon showed a decrease in 
plasma choline levels of about 40% [16,17].
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Phosphatidylcholine Supplementation Prior to Activity can 
Prevent Decline of Choline Levels and might improve 
Performance
Cycling
Von Allwörden suggested that choline supplementation
prior to exercise can prevent the decrease in choline levels
from hard physical stress and that this could affect per-
formance [5]. Ten top level triathletes performed two sets
of two hour cycling exercise at an average speed of 35 km
per hour. The participants received either a placebo or 0.2
g PC (90%) per kg body mass. Phosphatidylcholine sup-
plementation without exercise led to an increase in
plasma choline concentrations of approximately 27%.
Exercise without PC supplementation decreased the
plasma choline concentrations in the triathletes by an
average of 17%. When PC was given one hour before exer-
cise, average plasma choline concentrations remained at
the same level as the initial values (see figure 3).
Von Allwörden reported similar findings from a double-
blind, placebo-controlled, crossover pilot trial. Well-
trained endurance athletes performed a cycle ergometer
test for 2 hours. Subjects received either a placebo or 0.2 g
PC (90%) per kg body mass at breakfast 3 hours before
cycling at 1 Watt per kg body mass [18]. Plasma choline
values decreased after 2 hours of exercise by 38%. When
supplemented with PC, the average plasma choline levels
remained at the same level as the starting values.
Lower steady state heart rate, without an increase in blood
lactate concentration, at specific exercise intensities indi-
cates more efficient use of aerobic metabolism [25]. The
rate at which heart rate and blood lactate concentration
return to baseline values following exercise reflect the
effectiveness of the recovery processes. Lactic acid concen-
trations after 1 hour (break for taking blood samples) and
after 2 hours of exercise were increased by about 15%
without supplementation; however, PC supplementation
led to 11% decrease after one hour and a 25% decrease
after 2 hours of exercise [18] (see figure 4).
Influence of PC supplementation on lactic acid concentra- tions during exercise [18] Figure 4
Influence of PC supplementation on lactic acid concentra-
tions during exercise [18].
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Serum choline concentrations after ingestion of 2.3 g choline 
as choline chloride or PC [21,22].
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Influence of PC supplementation on plasma choline levels [5] Figure 3
Influence of PC supplementation on plasma choline levels [5].
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Phosphatidylcholine supplementation led to a decrease in
heart rate during the break for taking blood samples after
one hour of exercise [18] (see figure 5). The more rapid
return of heart rate to normal values after supplementa-
tion with PC when compared to placebo suggests that
increasing the availability of choline improved the recov-
ery following exercise. These findings confirm Mies et al.'s
placebo-controlled study on Lecithin (a mixture of PC, PS
and other PLs) in which supplementation resulted in
improved recovery in a bicycle ergometer trial [26,27].
Long Distance Runners
Von Allwörden investigated the effects of either placebo or
0.2 g PC (90%) per kg body mass on adolescent runners
(aged 14–20 years). The subjects performed cross-country
races of between 30 and 60 minutes, depending on age.
Phosphatidylcholine supplementation resulted in an 18%
increase in plasma choline levels with and a 54% increase
without exercise; however, runners without PC supple-
mentation did not deplete plasma choline levels [5].
In a follow-up trial well-trained endurance athletes (aged
25–28 years) were running with a velocity of 12 km per
hour for 2 hours. Subjects received either 0.2 g PC (90%)
per kg body mass at breakfast 3 hours before exercise or
did not receive a controlled diet [18]. Plasma choline val-
ues decreased after 2 hours of running by an average of
55%. When supplemented with PC average plasma
choline levels increased during three hours of rest. Physi-
cal stress lowered choline levels by 41%; however, final
values were still higher than initial values. Lactic acid val-
ues with PC supplementation were lower in 8 out of 10
runners and time to recover was 12% shorter.
More recently, Buchman et al. reported that supplementa-
tion with PC, in the form of lecithin, attenuated the exer-
cise-induced reduction of plasma choline concentrations
in marathon runners when compared to supplementation
with a placebo [28]. Actual race times were not different
from predicted race times and the authors concluded that
supplementation failed to improve performance. This
comparison should be viewed with caution as race times
during marathon running are difficult to predict due to
variations in courses and environmental conditions.
Studies with choline salts
In a double-blind, crossover, placebo-controlled clinical
trial ten long distance runners received either 2.8 g choline
citrate or placebo 1 hour prior to and again after complet-
ing 10 miles of a 20 mile run [19]. Plasma choline levels
were reported to have increased in the choline supple-
mented group, whereas they decreased in the placebo
group after strenuous exercise. The mean run time was
found to be significantly shorter when runners were sup-
plemented with choline when compared to placebo,
being 153.7 minutes and 158.9 minutes, respectively.
In clinical trials, in which athletes did not deplete choline
during exercise, choline supplementation did not result in
a delay of fatigue [29-31].
Spector at al. investigated the relationships between
plasma choline and fatigue during supramaximal brief
and submaximal prolonged cycling activities [29]. In a
placebo-controlled trial choline bitartrate supplementa-
tion resulted in an increase in choline plasma levels. Nei-
ther group depleted choline during either brief or
prolonged cycling training. Fatigue times and work per-
formed were similar under both conditions in each group.
It was concluded that choline was not depleted in either
condition nor did choline supplementation delay fatigue.
Deuster et al. investigated the effects of choline supple-
mentation on treadmill exercise in a double-blind crosso-
ver study [30]. Choline supplementation significantly
increased plasma choline concentrations. Exhaustive
physical activity did not deplete circulating choline levels
and consequently did not affect physical or cognitive per-
formance.
These findings confirm Warber et al.'s double-blind cross-
over study on choline citrate in which soldiers did not
deplete plasma choline levels and did not delay fatigue
during a four hour load carriage treadmill exercise [31].
Phosphatidylserine
Overtraining is a natural hazard of competitive sports. The
consequences of this condition can include decreased per-
formance, injury, depressed immunity and psychological
The effects of PC supplementation on mean heart rate during  ergometer training [18] Figure 5
The effects of PC supplementation on mean heart rate during 
ergometer training [18].
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depression [32,33]. A serious corollary of overtraining in
young female athletes is its propensity to decrease bone
density [34]. During early stages of overtraining, such as
when you work too hard during one or two exercise ses-
sions, muscles become sore, resting and submaximal exer-
cise heart rate and cortisol levels increase and testosterone
levels fall. The body has difficulties in adjusting, but usu-
ally recovers with a few days' rest. Chronic overtraining
often creates a disturbance in the ratio between the ana-
bolic hormone, testosterone, and the catabolic hormone
cortisol.
Phosphatidylserine was historically obtained from bovine
cortex (BC-PS). Due to the potential transfer of infectious
disease, this supplement is now considered unsuitable.
More recently, soy-derived phosphatidylserine (S-PS) has
become accepted as a safe alternative. Soy-PS is commer-
cially available as an oral supplement, with recommended
daily doses usually ranging from 100 to 500 mg.
Several double-blind, placebo-controlled clinical trials
have been performed to investigate whether phosphati-
dylserine supplementation (BC-PS and S-PS) prior to
exercise can prevent the exercise-induced increase in corti-
sol levels and improve other markers related to hard train-
ing.
Cycling
Eight non-physically trained healthy male volunteers
(aged 24–42 years) underwent two exercise trials, com-
posed of three distinct stages of cycle ergometry. The sub-
jects received intravenously either placebo or BC-PS 10
minutes before exercise. As expected, physical exercise
resulted in a significant increase in ACTH and cortisol lev-
els after administration of a placebo. Bovine cortex-PS
supplementation significantly suppressed ACTH and cor-
tisol responses to exercise [11] (see figure 6).
In a double-blind, randomized, placebo-controlled, cross-
over design, Monteleone et al. [35] showed that PS sup-
plementation suppressed cortisol and ACTH responses to
staged cycling exercise. Compared to placebo, cortisol lev-
els were 30% lower (800 mg S-PS), demonstrating that PS
supplementation can lessen the severity of stress
responses to exercise.
Kingsley et al. [36] recently reported a double-blind, pla-
cebo-controlled clinical trial where fourteen active males
completed staged intermittent exercise on three separate
occasions, (a familiarization trial followed by two main
trials that were separated by approximately 16 days). The
staged intermittent protocol consisted of three 10-min
stages of cycling at 45, 55 and 65% VO2max followed by a
final bout at 85% VO2max that was continued until exhaus-
tion. The exercise time to exhaustion was used as a meas-
ure of exercise capacity. After completing the first main
trial the subjects consumed either 750 mg of S-PS per day
or a placebo for 10 days. The main finding was that sup-
plementation influenced exercise capacity at 85% VO2max.
The group that received S-PS increased exercise times to
exhaustion by 29 ± 8%, while the exercise times to exhaus-
tion did not change following supplementation with pla-
cebo. Nevertheless, supplementation did not significantly
influence oxygen kinetic responses (MRTon or MRToff),
substrate oxidation, cortisol, and feeling states during the
trial.
Weight-Training
A 1998 study conducted at California State University
investigated the effect of PS on hormone levels, muscle
soreness and feelings of well-being when administered to
experienced weight-trained athletes [37]. During the two-
week training period, 11 weight-trained athletes (aged
22.8 ± 3.4 years) consumed either a placebo or 800 mg of
S-PS per day (double-blind, cross-over design). The
weight training program was designed to overtrain the
subjects. Subjects were instructed to use as much weight as
possible for each exercise and to train as hard as possible
for 4 days a week during each 2 week training period. Sub-
jective measures, such as perception of well-being and
muscle soreness were recorded throughout the training
period. Athletes had less muscle soreness when they were
taking S-PS compared to the placebo (see figure 7).
In addition, subjects had an improved perception of well-
being when taking S-PS, this was particularly evident after
the first week of training (see figure 8).
PS supplementation significantly suppresses ACTH and corti- sol responses to exercise [11] Figure 6
PS supplementation significantly suppresses ACTH and corti-
sol responses to exercise [11].
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Running Activities
A study conducted at the St. Cloud State University
showed that S-PS supplementation significantly lowered
creatine kinase (CK) activities in the circulation, a gener-
ally accepted indicator of cell membrane damage and
necrosis of the muscle fiber, 24 hours after exercise [38].
Twelve trained runners took either 300 or 600 mg S-PS per
day or a placebo for 15 days, then performed a 90-minute
run on the 15th day in this double-blind crossover study.
In healthy rested muscle, CK is contained within the mus-
cle plasma membrane. Intense exercise and activities,
where muscle damage occurs, causes an increase in CK
activities within the plasma and serum. PS supplementa-
tion was reported to reduce muscle damage in trained run-
ners compared to placebo (see figure 9).
A more recent double-blind, randomised, placebo-con-
trolled, crossover study investigated the effects of S-PS
supplementation on markers of muscle damage, inflam-
mation, muscle soreness and oxidative stress following
eccentric exercise-induced muscle damage [39]. Inde-
pendent of supplementation with S-PS (750 mg per day
for 10 days) or placebo, downhill running induced simi-
lar increases in circulating CK activities, myoglobin con-
centrations, interleukin-6 concentrations and
hydroperoxide concentrations.
Kingsley et al. [40] investigated the effects of oral supple-
mentation with 750 mg per day of S-PS for 10 days on oxi-
dative stress caused by exhaustive intermittent running
that was designed to simulate the movement patterns of
soccer with the addition of a performance run at the end
of the protocol. Although supplementation did not influ-
ence lipid peroxidation (as measured by hydroperoxide
concentrations), muscle damage (as measured by circula-
tory CK activities and myoglobin concentrations) and per-
ceived muscle soreness, supplementation with S-PS
tended to improve sprint and exercise performances when
compared to placebo. This double-blind, placebo-con-
trolled clinical trial demonstrated a potential ergogenic
property of S-PS.
Phosphatidylserine and Mental Stress
Mental and physical stress is closely linked and results in
similar physiological responses in the human body. Forty-
eight male undergraduate students received either 300 mg
S-PS or placebo for 30 days. Mental stress was induced by
performing a demanding mathematical task. Phosphati-
dylserine supplementation resulted in improvements in
feeling clear-headed, composed and confident, feeling
energetic and elated in a specific sub-section of the young
healthy students [10].
Hellhammer et al. investigated the effects of a three week
soy lecithin phosphatidic acid and phosphatidylserine
complex (PAS) supplementation to a mental and emo-
PS supplementation reduces circulatory Creatine Kinase  activities [38] Figure 9
PS supplementation reduces circulatory Creatine Kinase 
activities [38].
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PS supplementation significantly improves muscle soreness  [37] Figure 7
PS supplementation significantly improves muscle soreness 
[37].
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PS supplementation significantly improves well-being [37] Figure 8
PS supplementation significantly improves well-being [37].
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tional stressor [41]. 400 mg PAS resulted in a pronounced
blunting of serum ACTH and cortisol levels as well as pos-
itive effects on emotional responses compared to placebo,
however, higher doses (600 mg and 800 mg) did not
result in the same effects.
Phosphatidylserine has a long history in improving brain
functions that tend to decline with age. Numerous clinical
trials with PS have showed improvements in memory
tasks such as name-face delayed recall, facial recognition,
telephone-number recall and misplaced-objects recall
[42]. Phosphatidylserine supplementation has been
reported to improve long-term memory, long-term recog-
nition, as well as free speech and logic speaking [8]. It has
been observed that the interest in the environment and
the attention span were increased while loss of motiva-
tion, socialization and initiative were reduced [42].
Conclusion
Plasma choline levels can decrease during intense physical
activity of long duration. Where circulating choline con-
centrations have been demonstrated to decrease during
physical activity, choline supplementation has shown
benefit in improving performance.
The effective dosage in sport studies is 0.2 g PC (90%) per
kg body mass, which equals 2.1 g of choline for an 80 kg
athlete. There is no requirement for a loading or mainte-
nance phase and supplementation up to one hour before
exercise has been shown to be effective.
Phosphatidylserine has been demonstrated to be an effec-
tive supplement for combating exercise-induced stress
and preventing the physiological deterioration that
accompanies too much exercise (i.e. overtraining). Stud-
ies examining athletes involved in cycling, weight training
and endurance running suggest that PS might speed up
recovery, prevent muscle soreness, improve well-being,
and might possess ergogenic properties. Under some cir-
cumstances, PS has been reported to suppress cortisol.
This might protect muscle membranes against phosphol-
ipase damage, which is formed in response to muscle
trauma. In addition, PS could increase the rate of glucose
transported into muscle cells and, therefore, enhance
recovery of muscle glycogen following strenuous exercise.
The effective dosages in sport studies range from 300 to
800 mg PS per day for short-term application (10 -15
days). The effective dosage for mental stress, which is
closely related to physical stress, is 300 mg PS per day for
30 days. However, long-term studies on cognitive func-
tions have found significant physiological effects using
daily dosages as low as 100 mg PS per day. The lowest
effective dose for athletes is unknown.
Many of the richest dietary sources of PC and PS are also
high in cholesterol and fat. Egg yolk, meat and internal
organs are good sources of phospholipids. Whereas
grains, fruits and vegetables are relatively low in PC and
PS. Modern Diets are depleted of phospholipids (prima-
rily refined oils and fats, dehulled and cleaned raw mate-
rials). These changes in diet (low fat, low Cholesterol), as
well as the BSE crises (mad cow disease), have led to a
decrease in daily PS and PC consumption. Today's foods
contain approximately one third of the phospholipid lev-
els compared to the beginning of last century [7], which
could increase the athletes need for proper nutrition and/
or supplementation.
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